Table 3 Clinical cure rate at the isolate level: selected baseline isolates at test-of-cure visit (ME population)*
Isolate | Tigecycline | Comparator | ||
|---|---|---|---|---|
n/N | % | n/N | % | |
Staphylococcus aureus | 54/71 | 76.1 | 49/61 | 80.3 |
MRSA | 25/36 | 69.4 | 21/29 | 72.4 |
CA-MRSA | 17/25 | 68.0 | 17/23 | 73.9 |
MSSA | 29/35 | 82.9 | 28/32 | 87.5 |
Streptococcus spp. | 30/36 | 83.3 | 15/25 | 60.0 |
S. pyogenes | 8/11 | 72.7 | 5/5 | 100 |
S. agalactiae | 9/9 | 100 | 3/6 | 50.0 |
S. anginosus groupa | 8/9 | 88.9 | 3/8 | 37.5 |
Enterobacter cloacae | 5/8 | 62.5 | 1/1 | 100 |
Enterococcus spp. b | 5/7 | 71.4 | 6/6 | 100 |
Escherichia coli | 10/13 | 76.9 | 7/8 | 87.5 |
Klebsiella pneumoniae | 5/5 | 100 | 5/6 | 83.2 |
Proteus spp. c | 4/7 | 57.1 | 2/2 | 100 |
Pseudomonas aeruginosa | 5/7 | 71.4 | 2/2 | 100 |